Leuthold Group’s Sanofi SNY Stock Holding History

Leuthold Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-96,085	Closed	-$4.63M	–	244
2026 Q1	$4.63M	Buy	96,085 +2,235	+2%	+$104K	0.49%	88
2025 Q4	$4.55M	Buy	+93,850	New	+$4.65M	0.49%	87

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Leuthold Group's SNY Position: Q2 2026 in Review

Leuthold Group sold out of Sanofi (SNY) in Q2 2026, closing a stake of 96,085 shares — an estimated $4.63M sold.

Leuthold Group first reported a position in SNY in Q4 2025 and held it in 2 quarters. The position peaked at $4.63M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Leuthold Group reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
Leuthold Group sold 96,085 Sanofi shares in Q2 2026, an estimated $4.63M.
Leuthold Group first reported a position in Sanofi in Q4 2025 and held it in 2 quarters.
Leuthold Group's Sanofi position peaked at $4.63M in Q1 2026.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Leuthold Group's 13F filing for Q2 2026, filed 4 Aug 2026.